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Craniofacial development involves cranial neural crest (CNC) and mesoderm-derived cells. TGF-β signaling plays a critical role in instructing
CNC cells to form the craniofacial skeleton. However, it is not known how TGF-β signaling regulates the fate of mesoderm-derived cells during
craniofacial development. In this study, we show that occipital somites contribute to the caudal region of mammalian skull development.
Conditional inactivation of Tgfbr2 in mesoderm-derived cells results in defects of the supraoccipital bone with meningoencephalocele and
discontinuity of the neural arch of the C1 vertebra. At the cellular level, loss of TGF-β signaling causes decreased chondrocyte proliferation and
premature differentiation of cartilage to bone. Expression of Msx2, a critical factor in the formation of the dorsoventral axis, is diminished in the
Tgfbr2 mutant. Significantly, overexpression of Msx2 in Myf5-Cre;Tgfbr2flox/flox mice partially rescues supraoccipital bone development. These
results suggest that the TGF-β/Msx2 signaling cascade is critical for development of the caudal region of the skull.
© 2007 Elsevier Inc. All rights reserved.Keywords: Occipital somite; Cell proliferation; Differentiation; Occipital bone development; Cervical vertebrae; Myf5; TGF-β; Msx2; MouseIntroduction
Craniofacial development involves two distinct mesenchy-
mal cell lineages, mesoderm-derived cells and cranial neural
crest cells (ectomesenchymal cells), both of which give rise to
skeletal and mesenchymal tissues (Morriss-Kay, 2001; Noden
and Trainor, 2005). Craniofacial bone is divided into two
components, the neurocranium and the viscerocranium. The
neurocranium forms the braincase and is constructed from both
mesodermal- and neural crest-derived structures. The viscer-
ocranium develops from the pharyngeal arch complex, forms
the anterior part of the face, and is composed entirely of neural
crest-derived structures (Kuratani, 2005).
Recently, transgenic mouse models have revealed the
significance of TGF-β signaling in regulating craniofacial
development. Tgfb2 null mice show defects in the supraocci-⁎ Corresponding author. Fax: +1 323 442 2981.
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doi:10.1016/j.ydbio.2007.07.038pital and alisphenoid bones and the pterygoid process. These
mice also have small mandibles and lack coronoid and
condyle processes, which are neural crest-derived elements
(Sanford et al., 1997). Tgfb2−/−;Tgfb3−/− mice also show skull
defects in both mesoderm- and neural crest-derived structures
(Dunker and Krieglstein, 2002). The conventional knockout
model of Smad2, one of the intercellular mediators of TGF-β
signaling, shows compromised facial axis formation during
embryonic development (Heyer et al., 1999). Some haplosuf-
ficient Smad2 mice show loss of the mandible and eye
(Nomura and Li, 1998, our unpublished data). Taken together,
these findings imply that TGF-β signaling is critical for
patterning both neural crest cells and mesoderm-derived cells
during craniofacial development.
Multiple TGF-β isoforms induce a TGF-β signaling
response through type I and type II receptors. Previous study
has shown that Tgfbr2 null mutant mice die prematurely at day
E11.5, and chimeric mice show agnathia with anophthalmia and
hydrocephalus with internal hemorrhage (Oshima et al., 1996).
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generated Tgfbr2 conditional knockout mice using Cre-Loxp
recombinant technology in order to explore tissue specific
requirements for TGF-β signaling during embryonic develop-
ment. We have already reported that TGF-β signaling plays a
critical role in regulating neural crest cells during the
development of craniofacial structures (Ito et al., 2003; Sasaki
et al., 2006). In particular, Wnt1-Cre;Tgfbr2flox/flox mice show a
frontal bone (neurocranium) defect and small mandible
(viscerocranium). In the present report, we investigate the
function of TGF-β signaling in mesoderm-derived cells during
occipital bone development.
Myf5 is a member of the Myogenic Regulatory Factors
(MRFs) family and is implicated in the process of skeletal
muscle development (Braun et al., 1992; Weintraub et al.,
1991). Myf5 transcripts are first detected on embryonic day
E8.0 in cells of the dorsal medial quadrant of the somite in the
prospective epaxial domain (Ott et al., 1991; Tajbakhsh et al.,
1996). Myf5 expression is also detected at day E8.0 in the
occipital mesoderm, which gives rise to bone and muscle
components around the occipital area (Huang et al., 2000; Ott
et al., 1991). Furthermore, Myf5 null mice exhibit defects in
somite and rib formation, but not in muscle formation (Braun
et al., 1992; Grass et al., 1996). Clearly, Myf5 is expressed
broadly in mesoderm-derived cells, not limited to skeletal
muscle precursors. These characteristics suggest that Myf5-Cre
mice, when crossed with Tgfbr2 floxed mice, are a suitable
model for the investigation of the function of TGF-β signaling
in regulating mesoderm-derived cells during embryonic
development (Tallquist et al., 2000).
Myf5-Cre;Tgfbr2flox/flox mice survive until birth and show
defective supraoccipital bone development with meningoen-
cephalocele, discontinuity of the neural arch of the C1
vertebra, and accelerated differentiation of chondrocytes.
Expression of Msx2, a critical factor for dorsoventral axis
formation (Takahashi and Le Douarin, 1990; Takahashi et al.,
1992), is diminished in the mid-dorsal area at day E10.5.
Moreover, transgenic mice overexpressing Msx2 exhibit a
partial rescue of the supraoccipital bone defect in Tgfbr2
mutant mice. Our findings suggest that the TGF-β/Msx2
signaling cascade plays an important role in regulating the
development of the occipital somite-derived caudal region of
the skull.
Materials and methods
Generation of Myf5-Cre;Tgfbr2flox/flox and
Myf5-Cre;Tgfbr2flox/flox;Msx2TG/+ mice
All animal studies were performed according to IACUC guidelines. Myf5-
Cre transgenic mice have been described previously (Tallquist et al., 2000). We
crossed Myf5-Cre;Tgfbr2flox/+ with Tgfbr2flox/flox mice to generate Myf5-Cre;
Tgfbr2flox/flox null alleles that were genotyped using PCR primers as previously
described (Chytil et al., 2002).
Myf5-Cre;Tgfbr2flox/flox;Msx2TG/+ mice were described previously (Liu et
al., 1999). To confirm the overexpression of Msx2 gene, PCR was
performed using standard methods (Hosokawa et al., 2005). mRNA was
extracted from the dorsal side of somites at E10.5 following standard
methods.Two-component genetic system for marking the progeny of
somite-derived cells
The R26R conditional reporter allele has been described previously
(Soriano, 1999). We mated Myf5-Cre and R26R mice to generate Myf5-Cre;
R26R embryos. Detection of β-galactosidase activity in whole embryos (E9.5)
was carried out as previously described (Chai et al., 2000).
Myf5-Cre/R26R reporter assay
Myf5-Cre;Tgfbr2flox/+micewere crossedwithTgfbr2foxl/flox;R26Rflox/floxmice
to produce embryos with the genotype of Myf5-Cre;Tgfbr2flox/flox;R26Rflox/+.
β-galactosidase analysis was carried out as described (Sasaki et al., 2006).
Staining of whole skeleton
Whole skeletal preparations of newborn mice were prepared and stained
with Alizarin Red and Alcian Blue as previously described (McLeod, 1980).
Histological analysis
Tissues were fixed in 4% paraformaldehyde in phosphate buffered saline,
decalcified in Decalcifying solution (Richard-Allan Scientific, Kalamazoo, MI),
paraffin embedded, sectioned at 7 μm and stained with hematoxylin/eosin and
Safranin O/Fast Green. For immunostaining, tissue sections were incubated with
anti-Myf5 (1:500, Santa Cruz biotechnology Inc, Santa Cruz, CA), anti-TGF-β
IIR (1:100, Santa Cruz biotechnology Inc, Santa Cruz, CA) and anti-CD45
antibody (1:50, Santa Cruz biotechnology Inc, Santa Cruz, CA) using standard
procedures. For Safranin O/Fast Green staining, deparaffined and rehydrated
sections were stained in hematoxylin (Sigma, St. Louis, MO), 0.001% Fast
Green (Sigma) followed by a rinse in 1% acetic acid and 0.1% Safranin O
(Sigma) (Stickens et al., 2004).
BrdU labeling/histology
A 10 mg/ml stock of bromodeoxyuridine (BrdU; Sigma, St Louis, MO) was
injected intraperitoneally into mice at E13.5 and E14.5 at a dose of 100 μg BrdU
per gram of body weight. Mice were sacrificed 1 h after injection and embryos
were harvested. BrdU staining was carried out on paraffin sections by using a
BrdU staining kit according to manufacturer's directions (Zymed, South San
Francisco, CA).
In situ hybridization
Whole-mount and sectioned in situ hybridization were performed according
to standard procedure (Wilkinson, 1998). Several negative controls (sense probe
and no probe) were run in parallel with the experimental reaction. RNA probes
were generated as reported previously: Type I collagen (Sasaki et al., 2006),
Msx1 (Ishii et al., 2005), Msx2 (Ishii et al., 2003), and Shh (Hui and Joyner,
1993).
Organ culture of wild type and Myf5-Cre;Tgfbr2flox/flox mutant
mid-dorsal element explants
Timed-pregnant mice were sacrificed on postcoital day 10.5 and staged
according to somite age. Mid-dorsal region including otic vesicle were cultured
in serumless, chemically-defined BGJB medium according to standard methods
(Chai et al., 1994).
Preparation and introduction of TGF-β beads
For delivery of TGF-β1 or TGF-β2, we used affi-gel blue beads
(BioRad, Hercules, CA), diameter 50–80 μm. The beads were washed in
phosphate-buffered saline (PBS) and then incubated for 1 h at room
temperature in 10 μg/ml TGF-β1 or TGF-β2 (R&D, Minneapolis, MN).
Control beads were incubated in 0.1% BSA. TGF-β or BSA-containing
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the explant. In wild-type and Tgfbr2flox/flox;Myf5-Cre mutant samples, one
side of the mid-dorsal region was treated with BSA beads and the other
side treated with TGF-β beads.Fig. 1. Mesoderm-derived structures are positive for Myf5-directed expression
of lacZ. Lateral view of lacZ staining (blue) of Myf5-Cre;R26Rflox/+ whole-
mount E9.5 samples (A) and cross sections of E9.5 (B), E13.5 (C, D), E15.5
(G) and E17.5 samples (E, F). (A) LacZ staining is detectable in somites but not
the paraxial mesoderm cells in the craniofacial region. (B) Mesoderm-derived
cells in the occipital somite area show lacZ expression. (C, D) The primordia of
the supraoccipital bone (SO) and the neural arch of C1 (C1) are populated by
lacZ positive somite–derived cells. Non-blue cells are visible in the ventral area
of the SO and the cartilage primordium of the petrous part of the temporal bone
(pt) (C, black arrow). (E) Chondrocytes in the supraoccipital bone are lacZ
positive. (F) Cells in the parietal bone (pr) and frontal bone (fr) (dashed line)
are negative for lacZ staining. (G) Chondrocytes and osteoblasts in the humerus
are lacZ negative (white arrow). Myogenic cells are LacZ positive around the
humerus (black arrow). (H) Myf5 immunostaining of E13.5 Myf5-Cre;R26R-
mice. Chondrocytes in the supraoccipital bone primordium are positive for
Myf5 (arrowheads). Scale bars: 100 μm in panel B, 500 μm in panels C, D,
300 μm in panels E–G, 50 μm in panel H.Results
Myf5 promoter-driven LacZ positive cells populate
mesoderm-derived structures
In order to investigate Cre recombination under the control
of the Myf5 promoter, we generated Myf5-Cre;R26Rflox/+
mice. Whole mount lacZ staining revealed that somites were
positive (Fig. 1A). We stained sections to analyze the pattern
and time course of the Cre recombination driven by the Myf5
promoter (Figs. 1B–F). Somite-derived cells were lacZ
positive (Fig. 1B). Furthermore, E13.5 Myf5-Cre;R26Rflox/+
embryos displayed unexpected LacZ positive cells in skeletal
elements (Figs. 1C, D). LacZ positive cells were present not
only in musculature primordia but also in the primordia of the
supraoccipital bone, the neural arch of C1 vertebra, and the
perichondrium of these primordia (Figs. 1C, D). At later
developmental stages, a pattern of the lacZ craniofacial
staining emerged based on cell origin. Supraoccipital bone, a
somite-derived structure, possessed lacZ positive cells (Fig.
1E). On the other hand, the parietal bone, which is paraxial
mesoderm-derived and not a somite-derived structure, was
lacZ negative (Fig. 1F). To eliminate the possibility that
osteoblasts and chondrocytes possess endogenous β-galacto-
sidase activity, we checked the humerus, a lateral mesoderm-
derived component. LacZ staining was seen only in myogenic
cells (Fig. 1G, black arrow) but not the skeletal element (Fig.
1G, white arrow). In addition, we confirmed the localization of
endogenous Myf5 expression in the supraoccipital bone
primordium using immunohistochemistry. Myf5 positive
nuclei were detectable in the primordium of the supraoccipital
bone (Fig. 1H). Taken together, these results suggest that Cre
recombination driven by the Myf5 promoter will be produced
only in somite-derived mesoderm cells that contributed to
caudal skull development.
Myf5-Cre;Tgfbr2flox/flox mice show altered posture and
hemorrhage around the occipital area at birth
After crossing Tgfbr2flox/flox and Myf5-Cre;Tgfbr2flox/+
mice, we obtained 42 out of 127 pups that were Myf5-Cre;
Tgfbr2flox/flox. The ratio of newborn mice in the experimental
group was slightly higher than the expected Mendelian ratio
(33% verse 25%), suggesting that all conditional knockout
mice could survive until birth. These Tgfbr2 knockout mice
showed a hunchback phenotype (Fig. 2A) and hemorrhage
in the occipital area (Figs. 2A–C). Furthermore, the
knockout produced meningoencephalocele in the occipital
area and lethality at birth (Figs. 2D, E). To confirm that
these defects were the result of Tgfbr2 gene inactivation, we
examined the expression of TGF-β IIR in the supraoccipital
bone primordium. TGF-β IIR was expressed in thesupraoccipital bone primordium (Fig. 2F, black arrows)
and the temporal bone primordium (Fig. 2F, white arrows)
in the Myf5-Cre;Tgfbr2flox/+ sample, whereas it was
inactivated in the primordium of the supraoccipital bone in
the Myf5-Cre;Tgfbr2flox/flox sample. However, the primor-
dium of the temporal bone, a LacZ negative area (see Fig.
1C), appeared to contain TGF-β IIR positive cells (Fig. 2G,
white arrows). These observations indicated the successful
and specific inactivation of the Tgfbr2 gene by Cre-mediated
recombination.
Fig. 2. Myf5-Cre;Tgfbr2flox/flox mouse pups show altered posture and
meningoencephalocele in the occipital area. (A) Myf5-Cre;Tgfbr2flox/flox mice
(right) display a hunchback phenotype and hemorrhage in the occipital area
(white arrowhead). (B, C) Swelling is associated with the hemorrhage in the
occipital area (white arrow) in the conditional knockout mouse (C.K.O.). (D, E)
Peeling the skin above the swelling area reveals the excrescence of the brain in
the occipital area (white arrows). (F, G) Immunostaining of TGF-β type II
receptor in the supraoccipital bone primordium ofMyf5-Cre;Tgfbr2flox/+ (F) and
Myf5-Cre;Tgfbr2flox/flox (G) mice. Brown color indicates TGF-β type II receptor
expression in the supraoccipital bone primordium (black arrows). White arrows
indicate immunopositive cells in the lacZ negative area (see Fig. 1C).
Abbreviations: CL, cerebellum; OL, occipital lobe. Scale bars: 1 cm in panel
A, 5 mm in panels B–E, 100 μm in panels F, G.
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bone formation at the newborn stage
We used Myf5-Cre;Tgfbr2flox/+ mice as control samples,
and their development was indistinguishable from wild type.
In control mice, the skull vault consists of the frontal,
parietal, interparietal, and supraoccipital bones, from anterior
to posterior (Figs. 3A, E). Although the frontal, parietal,
and interparietal bones of conditional knockout mice
developed normally, the supraoccipital bone was diminished
at birth (Figs. 3B, F). There was only a small fragment ofsupraoccipital bone in the conditional knockout mice (Fig.
3J, black arrow), much smaller than that of control mice
(Fig. 3I). In control mice, the foramen magnum, composed
of the basioccipital, exoccipital, and supraoccipital bones,
was conjugated with cartilage tissue (Fig. 3M). In condi-
tional knockout mice, the foramen magnum was discon-
nected from the cartilage, most likely because of the
diminished supraoccipital bone (Fig. 3N). Conditional
knockout mice also showed disconnection of the C1 vertebra
(Figs. 3Q, R).
Dorsal endochondral ossification defects in
Myf5-Cre;Tgfbr2flox/flox mice
The skull vault has two ossification systems, intramem-
branous and endochondral (Noden, 1988). Quail–chicken
chimera experiments have shown that the supraoccipital bone
contains somite-derived cells and undergoes endochondral
ossification (Couly et al., 1993; Huang et al., 2000). In the
process of forming the supraoccipital bone and the neural
arch of the vertebrae, the cartilage tissue expands into the
middle of the dorsal region, and then each side of cartilage
fuses. After that, endochondral ossification, the process the long
bones of the trunk use for osteogenesis, begins in the
supraoccipital bone and the neural arch of the vertebra (Figs.
4A, C, M, O). At birth, the control mice (Myf5-Cre;Tgfbr2flox/+)
showed continuous bone formation from lateral to dorsal (Fig.
4A, arrowheads), and the base of the supraoccipital bone
contained chondrocytes (Fig. 4C). In contrast, conditional
knockout mice (Myf5-Cre;Tgfbr2flox/flox) showed hypoplasia
of the supraoccipital bone such that the primordium could not
expand towards the dorsal midline (Fig. 4B, black arrow) and
part of the brain was outside the skull (Fig. 4B, white arrow).
These hypoplastic supraoccipital bone primordia had already
been transformed from cartilage to bone tissue (Fig. 4D).
Each side of the neural arch of the C1 vertebra extended to
the dorsal midline and then fused with the cartilage tissue in
the control mouse (Figs. 4M, O). In contrast, each neural arch
in the conditional knockout mice was disconnected in the
dorsal region (Fig. 4N, asterisk). It appears that the edge of
the neural arch contains only the hypertrophic zone (Fig. 4P).
Safranin O staining clearly showed that conditional knockout
mice lost the proliferating and resting zones in the
supraoccipital bone and the neural arch of C1 vertebra at
the newborn stage (Figs. 4E–H, Q–T). The supraoccipital
bone of the conditional knockout mice instead contained a
bone marrow-like structure (Fig. 4H, arrow), and the
hypertrophic zone delineated the edge of the neural arch
(Fig. 4T). Furthermore, we examined the expression of the
Type I collagen gene, a marker for osteoblasts (Sasaki et
al., 2006). In the control mice, only the bone adjacent to the
hypertrophic zone contained Type I collagen positive cells
(Fig. 4I). Strikingly, Type I collagen positive cells were
detectable in the region of the hypotrophic as well as the
hypertrophic zone in supraoccipital bone of Myf5-Cre;
Tgfbr2flox/flox mice (Fig. 4J). To confirm the bone marrow
structure, we performed immunostaining for CD45, a marker
Fig. 3. Supraoccipital bone defect in Myf5-Cre;Tgfbr2flox/flox newborn pups. Alizarin red/Alcian blue-stained skeletons of Myf5-Cre;Tgfbr2flox/+ (control; A, E, I,
M, Q), Myf5-Cre;Tgfbr2flox/flox (B, F, J, N, R), Msx1−/− (C, G, K, O, S), and Msx2−/− (D, H, L, P, T) mice, showing side (A–D), dorsal (E–L), and ventral
(M–P) views and C1 vertebrae (Q–T). Panels I, J, K, and L are enlarged from the boxes of panels E, F, G, and H, respectively. (A, E) The control mouse
contains a frontal (fr), parietal (pr), interparietal (ip), and supraoccipital bone (so). (B, F, J, N) The supraoccipital bone of the conditional knockout mouse is
hypomorphic (Λso, black arrow). (C, G, K) The Msx1−/− mouse shows normal development of the supraoccipital bone. (D, H, L) The Msx2−/− mouse shows a
diminished supraoccipital bone (Λso, black arrow). (M) The occipital bone surrounding the foramen magnum dorsally (black arrowhead) is continuous in the
control mouse. (N) The conditional knockout mouse shows a gap in the dorsal portion of occipital bone (white arrowhead) and a diminished supraoccipital
bone (black arrow). (O, P) The Msx1−/− and Msx2−/− mice have continuous occipital bones forming the foramen magnum (black arrowheads). (Q, R) The
conditional knockout mouse shows a disconnection dorsally in the neural arch of the C1 vertebra (white arrowhead). (S, T) The C1 vertebrae in both Msx1−/−
and Msx2−/− mice appear normal. Abbreviations: bo, basioccipital bone; C1, the neural arch of first cervical vertebra; eo, exoccipital bone. Scale bars: 5 mm in
panels A–H, 2 mm in panels I–T.
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CD45 positive cells within the bone structure (Figs. 4L) in
the Myf5-Cre;Tgfbr2flox/flox mice, implying that bone marrow
was contained within the bone. These observations suggest
that the endochondral ossification process was compromised
in the supraoccipital bone and C1 neural arch of Myf5-Cre;
Tgfbr2flox/flox mice.Compromised perichondrium formation and muscle
attachment in Myf5-Cre;Tgfbr2flox/flox mice
In order to understand the cause of the endochondral
ossification defects in Myf5-Cre;Tgfbr2flox/flox mice, we exam-
ined the early development of the supraoccipital bone and the
neural arch of C1 at E15.5. Typically, the perichondrium of both
Fig. 4. The supraoccipital bone and the C1 vertebra fail to fuse in the mid-dorsal area inMyf5-Cre;Tgfbr2flox/flox newborn mice. Hematoxylin and Eosin (H.E.) staining
(A–D, M–P) and Safranin O staining (E–H, Q–T) of cross sections from the supraoccipital bone (A–L), and the neural arch of C1 vertebra (M–T) in control andMyf5-
Cre;Tgfbr2flox/flox mice (C.K.O.). Panels C, D, G, H, O, P, S, T are enlarged areas from the boxes in panels A, B, E, F, M, N, Q, and R, respectively. (A, C) The
supraoccipital bone of control mice extends to the mid-dorsal area (black arrowheads) and contains cartilage structure at the base of the bone. (B, D) Myf5-Cre;
Tgfbr2flox/flox mice have a shorter extension of the supraoccipital bone (arrow indicates the edge of bone) and a conversion of cartilage into bone structure. Part of the
brain is outside the skull vault (B, white arrow). (E, G) The cartilage in the supraoccipital bone base of control mice contains hypertrophic (h), proliferating (p), and
resting (r) zones. (F, H) The base of the supraoccipital bone in the conditional knockout mice contains only a small hypertrophic zone, and the remainder is replaced by
bone tissue (black arrow). (I, J) Type I collagen expression in the supraoccipital bone of control (I) and Myf5-Cre;Tgfbr2flox/flox (J) mice (black arrows). (K, L)
Immunostaining of CD45, a marker of hematopoietic cells, in control (K) and Myf5-Cre;Tgfbr2flox/flox (L) mice. CD45 positive cells (brown color, arrowheads) are
detectable adjacent to bone in the Myf5-Cre;Tgfbr2flox/flox sample. (M, O) The right and left sides of the neural arch of C1 vertebra are connected with cartilage mid-
dorsally in the control mice. (N, P) The neural arch of C1 vertebra in Myf5-Cre;Tgfbr2flox/flox mice does not extend to the dorsal midline (asterisk). (Q, S) The mid-
dorsal cartilage of control mice contains hypertrophic (h), proliferating (p), and resting (r) zones. (R, T) The edge of the neural arch, which does not extend to the
midline, contains only a hypertrophic zone in the and Myf5-Cre;Tgfbr2flox/flox mice. Abbreviations: pt, petrous part of temporal bone; sc, spinal cord. Scale bars:
500 μm in panels A, B, E, F, M, N, Q, R, 300 μm in panels C, D, G, H, I, J, O, P, S, T, 50 μm in panels K, L.
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area (Figs. 5A, C, K, M). In control mice, the perichondrium
was well formed (Fig. 5C, black arrow), and muscle tissueformed several layers and extended to the dorsal area (Fig. 5C,
black arrowheads). In contrast, the expansion of muscle tissue
was compromised in the conditional knockout mice (Fig. 5B,
Fig. 5. Development of cartilage and muscle tissue is compromised in the mid-dorsal region ofMyf5-Cre;Tgfbr2flox/floxmice. Hematoxylin and Eosin (A–D, K–N) and
Safranin O (E–H, O–R) staining of cross sections of the supraoccipital bone (A–H) and the C1 vertebra (K–R) in control and Myf5-Cre;Tgfbr2flox/flox mice. Panels
C, D, G, H, M, N, Q, and R are enlarged from the boxes of panels A, B, E, F, K, L, O, and P, respectively. (A, C) Muscle tissue forms continuous layers extending
into the mid-dorsal region (black arrowheads) in control mice, and the dorsal tip of the perichondrium is expanding in the dorsal direction (black arrow). (B, D)
Muscle tissue of conditional knockout mice does not extend into the mid-dorsal region (B, white arrowheads), and the perichondrium is disorganized at the dorsal tip
(D, white arrow). (E–H) The primordium of the supraoccipital bone contains undifferentiated cartilage tissue in both control and conditional knockout mice. (I, J) Type
I collagen (Col I) expression in control (I) and Myf5-Cre;Tgfbr2flox/flox (J) mice. Col I was expressed in the dorsal tip of the perichondrium (black arrow) in control
mice. Col I expression was compromised in the dorsal tip (white arrow) of conditional knockout mice. Col I expression was detectable surrounding the membrane of
the supraoccipital bone primordium (black arrows). (K, M) The perichondrium from both sides of the neural arch is fused in the mid-dorsal region in control mice
(black arrow). (L, N) The neural arch has detached in the dorsal area of the conditional knockout mice (white arrow). Muscle has attached to bone at the tip of the neural
arch of C1 vertebra (white arrowhead). (O–R) Both control and conditional knockout mice have three zones, hypertrophic (h), proliferative (p), and resting (r). Scale
bars: 200 μm in panels A–H and K–R, 100 μm in panels I–J.
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the tip of the cartilage (Fig. 5D, white arrow). The disorganized
perichondrium was seen in the serial sections of supraoccipital
bone primordium throughout the rostral to caudal regions
(Supplement figure). We also observed the disorganization of
the perichondrium at the level of the neural arch of C1 vertebra
(Figs. 5L, N, white arrow). Furthermore, muscle attachment to
the primordium of the neural arch occurred early in conditional
knockout mice (Fig. 5N, white arrowhead), beginning at E14.5(data not shown). However, we did not observe any problems
with organization at the lower level of cervical vertebra (data
not shown). Interestingly, the differentiation of cartilage in the
conditional knockout mice was indistinguishable from that of
control mice at E15.5 (Figs. 5E–H, O–R). The primordia of
the supraoccipital bone were composed of undifferentiated
chondrocytes in both control and conditional knockout mice
according to histological analysis (Figs. 5G, H). The pri-
mordia of the neural arch possessed three zones, hypertrophic,
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knockout mice (Figs. 5Q, R). Furthermore, we assessed Type
I collagen expression to confirm whether osteogenic differ-
entiation was accelerated. In control mice, the dorsal tip of
the perichondrium was positive for Type I collagen (Fig. 5I),
implying that osteogenic precursors populated the area. In
Myf5-Cre;Tgfbr2flox/flox mice, Type I collagen expression
was compromised in the dorsal tip (Fig. 5J, white arrow).
On the other hand, we detected Type I collagen expression in
the surrounding membrane of the primordium (Fig. 5J, black
arrows), implying that osteogenic differentiation was acceler-
ated in Myf5-Cre;Tgfbr2flox/flox mice.
Normal migration of dorsal mesoderm-derived cells in
Myf5-Cre;Tgfbr2flox/flox mice
Somites give rise to sclerotome and myotome, and then the
cells in the dorsal sclerotome migrate to the dorsal midline
(Christ et al., 2004; Christ et al., 2000). To assess the ability of
mesoderm-derived cells from somites to migrate toward the
dorsal midline, we collected early (E10.5) and middle (E13.5)
gestation samples. Cell migration from the lateral to the dorsal
area was indistinguishable in conditional knockout and control
mice at E10.5 (Figs. 6A, B, arrowheads). At E13.5, cellFig. 6. Cell migration from the dorsal sclerotome is unaffected in Myf5-Cre;
Tgfbr2flox/flox mice. Cross sections stained for lacZ at E10.5 (A, B) and E13.5
(C–F). (A, B) Control (A: Myf5-Cre;Tgfbr2flox/+;R26Rflox/+) and conditional
knockout (B: Myf5-Cre;Tgfbr2flox/flox;R26Rflox/+) mice contained mesoderm-
derived cells (dark blue) migrating into the mid-dorsal area (black arrowheads).
(C–F) Mesoderm-derived cells (black arrowheads) migrate to the mid-dorsal
region in both control and conditional knockout mice, arriving at the
supraoccipital bone (SO) and the neural arch of C1 vertebra (C1). Black arrows
indicate the dorsal midline. Abbreviations: NT, neural tube; eo, exoccipital bone.
Scale bars: 500 μm in panels A–F.migration was also normal in the primordia of both the
supraoccipital bone and the neural arch of the C1 vertebra in
conditional knockout mice (Figs. 6C–F), implying that the
dorsal endochondral ossification defects in the Myf5-Cre;
Tgfbr2flox/flox was not caused by abnormal migration of dorsal
mesoderm-derived cells.
Compromised Msx2 expression in the dorsal region of
Myf5-Cre;Tgfbr2flox/flox mice
We compared the skull defects of Myf5-Cre;Tgfbr2flox/flox
and Msx mutant mice, because Msx1 and Msx2 null mutants
exhibit skull malformations (Chai et al., 2003; Satokata et al.,
2000; Satokata and Maas, 1994). Msx2 null mice have a
supraoccipital bone defect, although the shape of the foramen
magnum is unchanged from wild type (Figs. 3D, H, L, P).Msx1
null mice exhibit normal formation of the supraoccipital bone
(Figs. 3C, G, K) and the foramen magnum (Fig. 3O). Both
Mxs1 and Msx2 null mice have normal formation of C1
vertebra (Figs. 3S, T). Although previous studies have shown
that Msx1 exhibits functional redundancy with the Msx2 gene
in some cases (Davidson, 1995; Ishii et al., 2005), our results
suggest that only Msx2 is involved in the formation of the
supraoccipital bone. TGF-β may control Msx2 gene expression
to regulate supraoccipital bone development.
We next explored the molecular mechanism responsible for
the caudal skull defects seen in the conditional knockout mice.
Msx1 and Msx2 are critical factors for dorsoventral axis
formation in vertebrae (Bach et al., 2003; Monsoro-Burq et al.,
1994;Monsoro-Burq et al., 1996) and Shh induces the formation
of ventral structures but inhibits the formation of dorsal
structures (Monsoro-Burq et al., 1994; Takahashi et al., 1992).
Based on our data, we hypothesized that Msx gene expression
would be compromised in the dorsal area of Tgfbr2mutant mice.
We found that the expression pattern of Msx2 in the Tgfbr2
sample was the same as that of the control mouse on the lateral
side of embryo (Figs. 7A, B), but was diminished in the dorsal
area from rostral to caudal (Figs. 7C, D, arrows). In contrast, the
Msx1 expression pattern in the conditional knockout mouse was
indistinguishable from that of the control mouse (Figs. 7E–H).
In addition, we observed no ectopic expression of Shh at the
dorsal midline in the conditional knockout mouse (Figs. 7K, L).
Shh was expressed at the tail bud and hind limb (Figs. 7I, J,
arrows). Thus, TGF-β signaling does affectMsx2 expression but
it does not affect Shh signaling. Subsequently, we investigated
whether Msx2 was expressed in the supraoccipital primordium
region at E12.5 when the undifferentiated mesoderm cells had
begun to aggregate. In control mice, Msx2 was expressed in
aggregated cells from ventral to dorsal (Fig. 7M). However, the
expression of Msx2 was restricted to the ventral area containing
a mixed population of LacZ positive and negative cells in
conditional knockout mice (Fig. 7N, see Fig. 1C, arrow). The
dorsal area of the supraoccipital primordium showed no Msx2
expression (Fig. 7N).
To address further whether TGF-β might control Msx2 gene
expression in the mid-dorsal area, we performed bead implanta-
tion experiments at E10.5. TGF-β2 beads induced Msx2 gene
Fig. 7. Msx2 gene expression is altered in the mid-dorsal area of Myf5-Cre;Tgfbr2flox/flox mice. Msx2 (A–D), Msx1 (E–H), and Shh (I–L) expression at E10.5 in
control (A, C, E, G, I, K) andMyf5-Cre;Tgfbr2flox/flox mice (B, D, F, H, J, L). (A, B, E, F, I, J) lateral views. (C, D, G, H, K, L) dorsal views. (A, B)Msx2 expression is
indistinguishable in lateral views of conditional knockout and control mice. (C, D)Msx2 is expressed in the mid-dorsal region extending from rostral to caudal (black
arrows) in control mice. Msx2 expression is diminished in conditional knockout mice throughout the mid-dorsal region (white arrows). (E–H) Msx1 expression in
conditional knockout mice is indistinguishable from control in the mid-dorsal line extending from rostral to caudal (black arrows). (I–L) Shh expression in conditional
knockout mice is indistinguishable from the control in the hind limb and tail bud (I, J, black arrows). Shh was negative at the dorsal area in both the control and the
conditional knockout mice (K, L). (M, N) Msx2 expression in mesenchyme cell cross sections at E12.5. Inserts show H.E. staining. Msx2 expression is visible
throughout the ventral region towards the dorsal region in the control mice (M, black arrowheads). Msx2 expression is restricted to the ventral side of conditional
knockout mice (N, black arrowheads). (O, P) Explants from the mid-dorsal area of E10.5 control and conditional knockout mice were treated with beads for 12 h. The
control sample (O) treated with TGF-β2 beads is positive for Msx2 expression (black arrows, dark blue), but BSA beads do not induce Msx2 expression (white
arrows). The conditional knockout sample treated with TGF-β2 beads is negative forMsx2 expression (P).Msx2 gene expression is visible around the otic vesicle (ov)
in both samples (black arrowhead). Scale bars: 1 mm in panels A–L, 100 μm in panels M, N, 200 μm in panels O, P.
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however, did not induceMsx2 gene expression (data not shown).
In contrast, TGF-β2 failed to induce the expression of Msx2 in
conditional knockout mice (Fig. 7P). These results suggest that
Msx2 is a target gene of TGF-β2 in the mid-dorsal area.
Overexpression of Msx2 rescues the supraoccipital bone defect
of conditional knockout mice
If Msx2 is a target gene of TGF-β signaling, Msx2 over-
expression might rescue defects in the Myf5-Cre;Tgfbr2flox/floxmice. To assess this possibility, we crossed Msx2 transgenic
mice (Msx2Tg/+;Tgfbr2flox/+), containing an exogenous Msx2
promoter-driven Msx2 gene (Liu et al., 1999), with Myf5-Cre;
Tgfbr2+/flox mice. We confirmed that Msx2 was overexpressed
in Msx2Tg/+;Tgfbr2flox/+ mice using PCR (Fig. 8A). Myf5-Cre;
Tgfbr2flox/flox;Msx2Tg/+ mice showed a hunchback phenotype
similar to that of the Myf5-Cre;Tgfbr2flox/flox mice and
microphthalmia, a phenotype of Msx2Tg/+ mice (Fig. 8B) (Wu
et al., 2003). However, we did not observe any hemorrhage
around the occipital area in Myf5-Cre;Tgfbr2flox/flox;Msx2Tg/+
mice (Figs. 8C, D). Furthermore, we examined supraoccipital
Fig. 8.Msx2 overexpression rescues the supraoccipital bone defect inMyf5-Cre;
Tgfbr2flox/flox mice. (A) Msx2 gene expression detected by PCR in control
(Tgfbr2flox/+) andMsx2-TG (Msx2Tg/+;Tgfbr2flox/+) samples at E10.5. (B) Whole
mount views of Myf5-Cre;Tgfbr2flox/+ (control), Myf5-Cre;Tgfbr2flox/flox;
Msx2-TG (transgenic) and Msx2-TG (transgenic) mice. The Myf5-Cre;
Tgfbr2flox/flox;Msx2-TG mouse has a hunchback phenotype like Myf5-Cre;
Tgfbr2flox/flox mice (black dotted line) and microphthalmia like the Msx2-TG
mouse (black arrows). (C) Dorsal view of the Myf5-Cre;Tgfbr2flox/flox mouse
shows the hemorrhage around the occipital area (black arrowhead). (D) Dorsal
view of the Myf5-Cre;Tgfbr2flox/flox;Msx2-TG mouse shows no hemorrhage
around the occipital area (white arrowhead). (E, F) Alizarin red and alcian blue
staining. In a dorsal view, the Myf5-Cre;Tgfbr2flox/flox mouse has a diminished
supraoccipital bone (E, black dotted line). The base of the supraoccipital bone is
formed but each side is disconnected in the mid-dorsal area (F, white dotted line)
in the Myf5-Cre;Tgfbr2flox/flox;Msx2-TG mouse. Abbreviations: C1, the neural
arch of C1 vertebra; eo, exoccipital bone; ip, interparietal bone. Scale bars: 1 cm
in panel B, 5 mm in panels C, D, 2 mm in panels E, F.
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overexpression partially rescued that defect (N=2) (Figs. 8E, F,
and see Fig. 3I). These results are consistent with a model in
which the absence of TGF-β signaling causes decreased
expression of Msx2 leading to the defect in the supraoccipital
bone. Thus, overexpression of Msx2 compensates for the lack
of TGF-β during the development of the supraoccipital bone
primordium. The rescue by Msx2 was only partial, so TGF-βmay also regulate other downstream target genes to control
supraoccipital bone development.
Compromised cell proliferation in the supraoccipital bone
primordium of Myf5-Cre;Tgfbr2flox/flox mice
To address whether there is a cell autonomous requirement
for TGF-β signaling during supraoccipital bone development,
we investigated cell proliferation in the perichondrium and
cartilage tissues of the supraoccipital bone primordia at E12.5,
E13.5, and E14.5. In control mice, musculature fiber formation
started at E13.5 (Figs. 9A, C) and the fiber was well formed at
E14.5 (Figs. 9G, I). In conditional knockout mice, we observed
disorganization of the musculature fiber at E15.5, which had
begun at E13.5 (Figs. 9B, D, H, J, white arrowhead). We also
observed disorganization of the perichondrium at E15.5 in the
conditional knockout mice (Fig. 5D), although this structure
was similar to wild type at E13.5 and E14.5 (Figs. 9D, J, black
arrow). We examined BrdU incorporation to determine whether
cell proliferation might be decreased in the conditional knock-
out mice. At E12.5, the cell proliferation activity in control and
conditional knockout mice was similar in the aggregated
mesoderm cell region, which gives rise to the supraoccipital
bone primordium (Fig. 9M). However, at E13.5 and E14.5,
chondrocyte cell proliferation was decreased in the primordium
of the supraoccipital bone in theMyf5-Cre;Tgfbr2flox/flox sample
(Figs. 9E, F, M). In the perichondrium, proliferation activity
was indistinguishable in control and conditional knockout mice
at E13.5 (Fig. 9M). Interestingly, proliferative activity of the
perichondrium decreased at E14.5 in control mice (Figs. 9K,
M). In contrast, proliferation persisted at E14.5 in conditional
knockout mice (Figs. 9L, M).
Discussion
The skull vault is constructed from two cell lineages,
CNC- and mesoderm-derived cells (Jiang et al., 2002;
Morriss-Kay and Wilkie, 2005). In this study, we have
found that TGF-β signaling is specifically required in somite-
derived bone structures, supraoccipital bone and C1 vertebra.
TGF-β signaling controls chondrocyte proliferation and
prevents premature cartilage differentiation to bone. Further-
more, loss of TGF-β signaling compromises the expression of
Msx2, but not Msx1, during supraoccipital bone development.
Significantly, overexpression of Msx2 in Myf5-Cre;Tgfbr2flox/flox
mutant mice partially rescues supraoccipital bone develop-
ment. These findings suggest that TGF-β signaling-mediated
Msx2 expression is critical for somite-derived caudal skull
development.
Occipital bone as evolutionary derivatives of vertebrae
Historically, Goethe first proposed a vertebral theory, in
which the skull is a form of vertebra. More recently,
evolutionary developmental biologists have suggested that the
occipital bone is one of the vertebrae and the supraoccipital
bone corresponds to the neural arch of the cervical vertebra
Fig. 9. The pattern of cell proliferation is altered in the supraoccipital bone primordium ofMyf5-Cre;Tgfbr2flox/floxmice. Cross sections of E13.5 (A–F) or E14.5 (G–L)
supraoccipital bone primordium stained with hematoxylin and eosin (A–D, G–J) or BrdU (E, F, K, L). (C–F, I–L) Enlarged areas from the dashed black boxes of
panels A, B, G, and H are shown in C/E, D/F, I/K, and J/L, respectively. (A, C) Control mice have well-organized perichondrium (C, black arrow) and muscle tissue (C,
black arrowheads). (B, D) The perichondrium of conditional knockout mice is organized (D, black arrow), but muscle tissue is disorganized (D, white arrowhead). (E,
F) Control and conditional knockout mice contain BrdU positive cells in the cartilage and the perichondrium of the supraoccipital bone (black arrowheads) and in the
muscle cells (black arrow). (G, I) The perichondrium (I, black arrow) and muscle tissue (I, black arrowheads) are well-organized in control mice. (H, J) Conditional
knockout mice have a well-organized perichondrium (black arrow), but disorganized muscle tissue (J, white arrowheads). (K, L) In control mice, BrdU positive cells
are present in both the cartilage and perichondrium of the supraoccipital bone (black arrowheads) and also in the muscle (black arrows). BrdU positive cells are visible
in the muscle (black arrows) and perichondrium (black arrowheads) of the supraoccipital bone in conditional knockout mice, but not in the cartilage of supraoccipital
bone. (M) Statistical analysis of cell proliferation activity in control and conditional knockout mice. Five randomly selected, non-overlapping samples were used to
obtain the BrdU labeling index from each experimental group. Student t-tests were used for statistical analysis.∗Pb0.05. Abbreviations: SO, the primordium
supraoccipital bone. Scale bars: 300 μm in panels A–L.
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Chicken and quail experiments have demonstrated that
mesoderm-derived cells contribute to the formation of occipital
bone. The cells from somite 1 and 2 are distributed into
supraoccipital bone, and the cells from somite 5 and 6
contribute to C1 vertebra (Huang et al., 2000). During
embryonic development, these somite-derived cells form the
dorsal sclerotome, which gives rise to the anlagen of the neuralarch of vertebra (Christ et al., 2004; Dockter and Ordahl, 1998).
It is unknown whether mesoderm-derived cells are distributed
into the supraoccipital bone in mice. In our present study,
somite-derived cells are LacZ positive (Myf5 promoter-driven),
but paraxial mesoderm cells are negative (see Fig. 1). Since
paraxial mesoderm gives rise to parietal bone (our unpublished
data), this explains why there is no defect in the formation of
parietal bone in Myf5-Cre;Tgfbr2flox/flox mutant mice.
151R. Hosokawa et al. / Developmental Biology 310 (2007) 140–153Significantly, LacZ positive cells, which derive from somites,
populate the primordia of the supraoccipital bone and C1 neural
arch. Thus, we report for the first time that somite-derived cells
can migrate into the anlage of the supraoccipital bone in the
mouse embryo. Furthermore, the supraoccipital bone is more
closely related to the cervical vertebra than the rest of the skull
in mice.
Msx genes are involved in the formation of the caudal skull
Chicken and quail experiments have revealed that Msx is a
critical factor in the formation of the dorsoventral axis
(Takahashi and Le Douarin, 1990; Takahashi et al., 1992).
For instance, notochord explantation into the dorsal area results
in the diminished expression ofMsx genes in the dorsal area due
to ectopic expression of Shh (Monsoro-Burq et al., 1994).
Consequently, the reduced expression of Msx genes causes a
defect of neural arch development in the dorsal area (Monsoro-
Burq et al., 1994). Although Msx1 and Msx2 show functional
redundancy in numerous tissues (Alappat et al., 2003), they
have unique expression patterns and functions in specific areas.
Msx1 null mice have development defects such as cleft
secondary palate, deficiency of the alveolar bone in the
mandible and maxilla, and failure of tooth development
(Satokata and Maas, 1994). On the other hand, Msx2 null
mice have defects in supraoccipital and frontal bone develop-
ment (Satokata et al., 2000). Overexpression of Msx2 in mice
results in skull defects that mimic the phenotype of human
Boston-type craniosynostosis (Liu et al., 1995; Liu et al., 1999).
These findings suggest that each Msx gene possesses a specific
expression pattern and plays a unique role in regulating
craniofacial development. In this study, we conclude that
Msx2 possesses an important function in supraoccipital bone
formation. Compromised Msx2 gene expression is likely to be
at least partly responsible for the supraoccipital bone defect in
the Tgfbr2 conditional knockout mouse, because overexpres-
sion of Msx2 in the Myf5-Cre;Tgfbr2flox/flox mice results in the
partial rescue of supraoccipital bone development.
TGF-β controls Msx2 expression in presumptive supraoccipital
bone primordia
As mentioned before, Msx2 null mice show intramembra-
nous and endochondral ossification defects (Satokata et al.,
2000), and the number of chondrocytes in their resting,
proliferating, and hypertrophic zones is decreased. In our
present study, cell numbers in these three zones are also
decreased, suggesting that TGF-β signaling is involved in
chondrogenesis by controlling Msx2 expression in undiffer-
entiated cells that give rise to endochondral bone. Previous
studies have suggested that Msx2 represses chondrogenesis
without causing cell death (Takahashi et al., 2001). Interest-
ingly, Sox9, a gene involved in chondrocyte differentiation, is
co-expressed with Msx2 in cranial neural crest cells. Msx2
expression is tightly linked to the expression of Sox9 around the
area of cartilage differentiation (Semba et al., 2000). The lack of
Msx2 in the supraoccipital bone primordium of Tgfbr2conditional knockout mice might result in the loss of a
chondrocyte differentiation repressor. Consequently, chondro-
cyte differentiation is accelerated in mesoderm-derived cells in
the Myf5-Cre;Tgfbr2flox/flox mouse.
TGF-β signaling regulates the expression of transcription
factors, which in turn regulate the fate of CNC cells by
controlling the progression of the cell cycle (Han et al., 2003;
Ito et al., 2003; Moses and Serra, 1996). For example, TGF-β
controls the expression of Msx1 in the CNC-derived palatal
mesenchyme prior to palatal fusion (Ito et al., 2003). BMP, a
member of the TGF-β family, is known to regulate Msx2
expression to control the fate of CNC cells during craniofacial
development (Brugger et al., 2004; Liu et al., 2005). In this
study, we discovered that TGF-β-mediated Msx2 expression is
critical for regulating the mesoderm-derived cells that con-
tribute to the development of the caudal region of skull. Clearly,
members of the TGF-β family play important roles in regulating
Msx gene expression during craniofacial development. Specific
TGF-β/BMP and Msx1/Msx2 regulatory interactions may help
to set up temporal and spatial specificity to achieve diverse
developmental outcomes during craniofacial morphogenesis. It
is important to point out that the lack of a completely rescued
supraoccipital bone development in Myf5-Cre;Tgfbr2flox/flox;
Msx2Tg/+ mice suggests that, in addition to Msx2, TGF-β
regulates the expression of other factors, underscoring the
complicated nature of the TGF-β signaling network in
regulating craniofacial morphogenesis.
TGF-β possesses an autonomous function for chondrocyte
differentiation in endochondral ossification
TGF-β plays an important role in regulating chondrocyte
proliferation and differentiation. The conditional inactivation of
Smad4, a TGF-β signaling mediator, causes decreased cell
proliferation and the maturation of chondrocytes (Zhang et al.,
2005). The maturation of chondrocytes is also faster in
dominant negative TGF-β type II receptor mice than wild-
type mice. Consequently, dominant negative mice develop a
degenerative joint disease resembling osteoarthritis in humans
(Serra et al., 1997). Col2a-Cre;Tgfbr2flox/flox mice, which lack
Tgfbr2 specifically in chondrocytes, show normal long bone
formation. However, occipital bones, formed by endochondral
ossification, exhibit malformations in these mutant mice (Baffi
et al., 2004). It is controversial whether TGF-β possesses an
autonomous function in chondrocytes or a non-autonomous
function whereby it affects chondrocytes through signaling in
the perichondrium. In the non-autonomous model, TGF-β is
required in the perichondrium to control the expression of Ihh
and PTHrP in cartilage (Alvarez et al., 2001; Alvarez et al.,
2002). Ihh and PTHrP are then required to inhibit the
differentiation of chondrocytes. However, Ihh/PTHrP signaling
inhibits the hypertrophic differentiation of chondrocytes
independently of Smad4-mediated TGF-β signals in Cola2-
Cre;Smad4flox/flox conditional knockout mice (Zhang et al.,
2005). Studies with Cola2-Cre;Smad4flox/flox mice also show
that TGF-β has an autonomous function to control the cell
proliferation and differentiation of chondrocytes. The present
152 R. Hosokawa et al. / Developmental Biology 310 (2007) 140–153study demonstrates that compromised TGF-β signaling within
the cartilage results in decreased proliferation of chondrocytes
and accelerated differentiation in the Myf5-Cre;Tgfbr2flox/flox
mutant. As chondrocytes in the Tgfbr2 mutant have lost their
ability to respond to TGF-β signaling, our results support a
model in which TGF-β possesses an autonomous function to
inhibit chondrocyte differentiation.
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